elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38137746-20166135-6405-472F-9336-D313ABBD8478
Q38137746-20166135-6405-472F-9336-D313ABBD8478
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38137746-20166135-6405-472F-9336-D313ABBD8478
TRAIL and microRNAs in the treatment of prostate cancer: therapeutic potential and role of nanotechnology.
P2860
Q38137746-20166135-6405-472F-9336-D313ABBD8478
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38137746-20166135-6405-472F-9336-D313ABBD8478
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3c41530532ef90cff86ccf02e8fd83618736442d
P2860
NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128.